RM45,000 Raised for CVSKL Foundation Through Charity Run

RM45,000 Raised for CVSKL Foundation Through Charity Run

Cardiac Vascular Sentral Kuala Lumpur (CVSKL) proudly announces the successful conclusion of its inaugural Charity Run on 17th November with over 1,700 participants. Flagged off by guest of honour, YB Datuk Dr. Mohd Radzi Jidin, Member of Parliament for Putrajaya, this event marked CVSKL’s 7th anniversary, aiming to raise awareness about cardiovascular diseases and support the CVSKL Foundation.

cs241127_CVSKL03
CVSKL Person-in-Charge, Datuk Dr. Rosli Mohd Ali (second from left) and Medical Director, Dato' Dr. Sharifah Suraya Mohd Tahir (fourth from the left) handed over a check worth RM45,000 to CVSKL Foundation Board of Trustees, Dato' Dr. Khodijah binti Abdullah (left) and Dato' Azzat Kamaluddin (second from right), witnessed by guest of honor Datuk Dr. Radzi Jidin (third from the left).

The fun run, which began at 7.20am saw participants of all ages, including families with young children and individuals with disabilities. Adding to the festivities, the event featured a walk-through giant heart structure and interactive educational and health screening booths promoting heart-healthy lifestyles. The run concluded with lucky draws and a mock cheque presentation by Datuk Dr. Rosli, Consultant Cardiologist and Person-in-Charge of CVSKL, to Dato’ Azzat Kamaluddin, a Board of Trustee member of CVSKL Foundation, witnessed by guest of honour, YB Datuk Dr. Mohd. Radzi Jidin.

“This run is not just about raising funds; it’s about fostering community engagement and uniting everyone to support a cause that profoundly impacts many lives. The generosity displayed here today sets a powerful example for all of us,” remarked Datuk Dr. Radzi, Member of Parliament for Putrajaya.

Datuk Dr. Rosli stated, “One of the four pillars that make us a Centre of Excellence is our commitment to corporate social responsibility and giving back to the community. This event is particularly special as it marks our 7th year anniversary in November—a perfect way to celebrate through wellness and supporting a worthy cause.”

CVSKL Foundation is a charitable, non-profit organisation established in 2022 to support education and awareness programmes on cardiovascular health, conducting research and extending financial support for underprivileged individuals suffering from cardiovascular conditions. Doctors from CVSKL contributed the first RM1 million to the foundation to jumpstart fundraising efforts. Since its inception, it has helped over 27 individuals.

cs241127_CVSKL02
The participants proudly show off their medals after finishing the 5km run.

“We are deeply grateful for the generous contribution from CVSKL. Every ringgit donated will go towards helping patients in need. We hope that this will inspire others to join us in our mission to raise funds to support our causes,” said Mr. Raymond Wong, Chief Executive Officer of CVSKL Foundation.

CVSKL extends its gratitude to all participants, organisers, and sponsors, including Kinohimitsu, MBT, TAGS Chiropractic & Rehabilitation, and Viatris for their invaluable support to the success of this event.

CVSKL Foundation appreciates its’ donors for their generous support. If you would like to make a donation, please email cvskl.foundation@cvskl.com. For more information on CVSKL, please visit www.cvskl.com.

Sources

    1. Malaysia Kini
    2. Cilisos
    3. Business Today
    4. Business News
    5. SME
    6. NewstreamAsia
    7. Asia News Channels
    8. Malaysian Business

CVSKL and Alpro Group Unite to Launch “Synergistic Hearts” Campaign for Enhanced Cardiovascular Care – NewStreamAsia

Kuala Lumpur, 14 February 2024 – Cardiac Vascular Sentral Kuala Lumpur (CVSKL) dan Alpro Group proudly announces the initiation of the “Synergistic Hearts” campaign. This collaborative effort seeks to elevate cardiovascular health within the community, with a specific emphasis on addressing irregular heart rhythms, commonly known as arrhythmia.

Atrial fibrillation (AF) is a type of irregular heart rhythm condition that affects the upper chambers (atria) of the heart. This arrhythmia prevents blood from being pumped efficiently to the rest of your body. AF itself is not life-threatening but if left undiagnosed and untreated, it can result in complications such as stroke and heart failure. It often manifests without obvious symptoms, allowing it to go undetected for long periods of time. Recognising the significance of early detection and intervention, the “Synergistic Hearts” campaign emphasises the importance of proactive measures to mitigate the impact of irregular heart rhythm. 

As part of this pioneering collaboration, CVSKL is providing 20 units of KardiaMobile Electrocardiogram (ECG/EKG) Monitor device, a cutting-edge technology that allows for a quick 30-second test to detect reliable, medical-grade ECG results. These devices allow customers to receive prompt results and advice from well-trained pharmacists, guiding them on the next steps in managing their cardiovascular health. The expertise of CVSKL’s reputable cardiologists and electrophysiologists, Datuk Dr. Razali Omar and Dr. Zulkeflee Muhammad has played a crucial role in shaping the campaign’s approach to addressing irregular heart rhythms, ensuring that the community receives the most advanced and comprehensive cardiovascular care.

Regarded widely as a tertiary referral centre, patients from all over Malaysia are referred to CVSKL to seek further cardiac and vascular treatment, especially if their cases are deemed complex by their primary doctor. CVSKL is strategically located in the nation’s transportation hub, KL Sentral where most of the passenger rail networks serve KL Sentral station. Recognizing this. CVSKL also has an initiative with KTMB and KLIA Ekspres to provide free return train tickets from the stations that arrive in KL Sentral. 

Tan Eng Ghee, Chief Executive Officer of CVSKL stated, “We are thrilled to embark on this partnership with Alpro Group, recognising the invaluable role pharmacists play in changing the narrative on how Malaysians

(L-R) Tan Eng Ghee (CEO of CVSKL) and Low Swee Siong (CEO of Alpro Pharmacy) officiating the collaboration.

should care for their hearts.  Together, we are dedicated to advancing cardiovascular care, ensuring that individuals receive the support they need for a healthier and heart-conscious community.

In appreciation of Alpro’s commitment to this partnership, CVSKL is extending a 10% discount to Alpro Pharmacy members and employees. This discount applies to CVSKL room rates (for self-paying patients), DishRoom restaurant services, PulsePoint Pharmacy products, and Health Screening Packages (HealthScan & Gastro), all available in CVSKL.

“We thank CVSKL for working with us as it will enhance our pharmacists’ ability to better serve the communities,” stated Ph Lim En-Ni, Chief Pharmacist. “Pharmacists play a unique role in the healthcare ecosystem, offering accessible and trusted healthcare advice alongside longer operating hours and convenient locations. This collaboration leverages these strengths, empowering us to identify potential risks early, guide patients towards appropriate next steps, and, above all, instil confidence and reassurance in every healthcare interaction, ultimately contributing to a healthier community.”

In an industry where collaborations between hospitals and retail pharmacies are rare, the partnership between CVSKL and Alpro Group, the holding company of Malaysia’s largest prescription pharmacy chain – Alpro Pharmacy, emphasises a common commitment to enhancing patients’ well-being. This strategic alliance recognises the distinctive role of pharmacists within the healthcare ecosystem who often develop personal connections with patients who frequent their pharmacies and are uniquely positioned to promote cardiovascular care. Klang Valley, Seremban and Johor have been selected for the initial phase of this collaboration.

To find out more about these exciting offers or for more information, please call or WhatsApp us at +603 2276 7002 during our normal office hours, email us at appointment@cvskl.com or visit our website at www.cvskl.com 

Sumber

CVSKL Performs Its First Successful MitraClip™ Procedure to Treat Mitral Valve Regurgitation

Kuala Lumpur, 10 August 2023 – Cardiac Vascular Sentral Kuala Lumpur (CVSKL) has recently performed its first MitraClip™ procedure, making them the one of the first private hospitals in Malaysia to offer this advanced treatment for mitral valve regurgitation.

“With MitraClip, in certain cases, we have the option to treat mitral valve regurgitation without open-heart surgery,” says Dr Al Fazir, consultant cardiologist at CVSKL.

The heart is a one-way pump that supplies blood to the entire body. It is made of four chambers and four valves and each valve has flaps (leaflets or cusps). Imagine the valves like a one-way swinging door that ensures blood flow in a single direction. It “swings” open to allow blood to flow to the next chamber/structure when the heart contracts and seals shut to stop the blood from leaking backwards.

One of the valves is called the mitral valve. In certain conditions, the flaps of the valve fail to seal completely or the valve’s size and shape have altered, causing the blood to leak backward. This leakage is called mitral valve regurgitation or mitral valve insufficiency. Left untreated, severe mitral valve regurgitation can cause heart failure and arrhythmias (irregular heart rhythm).

Because there is no chest incision, the MitraClip™ procedure offers an alternative over the conventional mitral valve surgery, making it an ideal treatment option for older, high-risk patients and those with underlying health conditions.

Led by consultant cardiologist, Dr. Al Fazir Omar, alongside consultant cardiologists Dr. Choo Gim Hooi and Datuk Dr. David Chew Soon Ping, the CVSKL team successfully performed the procedure, which lasted approximately four hours. Dr. Al Fazir expressed his elation regarding this significant milestone. He commented, “The MitraClip procedure offers a faster recovery time. The patient was discharged two days after the procedure. It is truly changing the treatment landscape for mitral valve regurgitation.”

Meet our Heart Team, a collaborative force of skilled cardiologists, anaesthesiologists, cardiothoracic surgeons and dedicated allied health professionals that made this achievement possible.

Dr Choo added, “This achievement wouldn’t have been possible if it weren’t for the exceptional teamwork and collaboration between our skilled cardiologists and the dedicated surgical team.” Dr. David also shared, “Advanced interventions like MitraClip require a dedicated heart team; I’d also like to thank our radiographers and nurses who are working hard alongside us in the cathlab.”

CVSKL’s achievement in performing its first successful MitraClip™ procedure marks a major leap forward in their institution in the treatment of mitral valve regurgitation. Their Structural Heart Program is further reinforced by this achievement with the addition of MitraClip™ under their belt, living up to their ethos of elevating CVSKL as a Centre of Excellence for all cardiovascular matters.

For more information, please call or WhatsApp +603 2276 7002 during normal office hours or email info@cvskl.com.

Sumber

 

CVSKL Marks 50 TAVI Cases for Severe Aortic Stenosis Treatment Milestone

Newstreamasia-CVSKL-50TH-TAVI

KUALA LUMPUR, 13 March 2023 – Cardiac Vascular Sentral Kuala Lumpur (CVSKL) Cardiology unit achieved a significant milestone by successfully completing its 50th Transcatheter Aortic Valve Implantation (TAVI) case recently. The first TAVI procedure was successfully performed at CVSKL in 2019.

The TAVI procedure is a highly complex, minimally invasive procedure indicated for individuals with severe aortic stenosis where surgery may not be suitable, especially in the older population. Aortic stenosis occurs when the valve between the left ventricle and aorta does not open completely due to calcification, making it difficult for blood to flow to the rest of the body. Heart valve disease is one of the leading causes of cardiovascular mortality and morbidity in the world and its’ degenerative pathology is attributed to the aging process, where surgery may not be suitable for older patients.

Consultant cardiologist, Datuk Dr Rosli is renowned for his pioneering work on the TAVI procedure and he is one of the two proctors in the country. Together with consultant cardiologists, Datuk Dr. Tamil Selvan Muthusamy and Dr. Choo Gim Hooi as second and third operators respectively, he led the team in a 2-hour long procedure to success. Commenting about the milestone, Datuk Dr Rosli shared that the ‘heart team’ is thrilled to cross this significant milestone and credited the entire team for this achievement. He added, “The TAVI procedure has been a game-changer in the treatment of severe aortic stenosis, providing options to patients who are not suitable to undergo open surgery. The outstanding teamwork here between my colleagues and the entire cath lab team ensures that all complex cases are well coordinated to ensure better outcomes and quality of care.”

Established in 2020, the Structural Heart Centre of Excellence program in CVSKL functions to diagnose and treat structural heart conditions that affect the heart’s valves, walls, chambers, and muscles of the heart. The group of conditions exists from birth or is caused by aging. CVSKL’s achievement of this milestone demonstrates its commitment to providing patients with the most advanced and innovative treatments available. The hospital continues to play a vital role in the advancement of heart healthcare in Malaysia and beyond.

For more information, please call or WhatsApp +603 2276 7002 during normal office hours or email info@cvskl.com.

Sumber